DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Yuen MF, Heo J, Jang JW. et al.
Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial.
Nat Med 2021;
27 (10) 1725-1734
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.